VIANA, Valéria Goulart et al. ORAL GLP-1 RECEPTOR AGONIST (ORFORGLIPRON) IN THE MANAGEMENT OF OBESITY AND TYPE 2 DIABETES. Seven Editora, [S. l.], p. 43–55, 2026. Disponível em: https://sevenpubl.com.br/editora/article/view/8968. Acesso em: 4 mar. 2026.